Aromatherapy Market to Expand with Significant CAGR During 2021 – 2028: Grand View Research Inc.

 Aromatherapy Market Growth & Trends

The global aromatherapy market size is anticipated to reach USD 3.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. Rising awareness regarding the positive impact of essential oils on the well-being and health of consumers coupled with the growing demand for natural products is likely to boost aromatherapy market growth over the forecast period.

Increased focus on mental health coupled with the rising adoption of essential oils for the management of mental health problems is expected to drive the market. Furthermore, the growing acceptance of aromatherapy in medical facilities, including clinics and hospitals, is anticipated to augment the demand for aromatherapy diffusers and essential oils.

The demand for aromatherapy in-home use is likely to witness significant growth amid the COVID-19 crisis on account of the lockdown measures taken by various governments, resulting in people staying at home. Furthermore, the demand for aromatherapy in hospitals and clinics also witnessed growth owing to the increased utilization by institutions for treating COVID-19, infected patients.

The growing adoption of aromatherapy for alleviating conditions such as anxiety, depression, nausea, and insomnia during the lockdown is expected to impact market growth positively. The demand for essential oils, especially tea tree and eucalyptus oil is expected to witness growth amidst the pandemic on account of their antiseptic and antibacterial properties.

Request a free sample copy or view report summary: Aromatherapy Market Report

Aromatherapy Market Report Highlights

• The demand for aromatherapy diffusers is expected to witness growth at an estimated CAGR of 8.8% from 2021 to 2028 owing to the growing preference for diffusers as they help in gaining the therapeutic benefits from essential oils
• The relaxation application segment accounted for 23.2% of the global revenue share in 2020 on account of an increase in the number of people suffering from stress and anxiety coupled with a growing preference for natural treatment to get relief from stress
• The e-commerce distribution channel segment is anticipated to witness growth at a CAGR of 12.2% over the forecast period on account of benefits associated with this channel, such as convenience, availability of a wide range of products, and ease-of-buying
• In September 2020, Stadler Form Aktiengesellschaft expanded its products offerings by launching Zoe, a glowing energy-efficient aroma diffuser that uses ultrasound technology to emit essential oils in the room

Access Press Release@ https://www.grandviewresearch.com/press-release/global-aromatherapy-market

Aromatherapy Market Segmentation

Grand View Research has segmented the global aromatherapy market on the basis of product, mode of delivery, application, distribution channel, end-use, and region:

Aromatherapy Product Outlook (Revenue, USD Million, 2017 - 2028)

• Consumables
  • Essential Oils
    • Singles
      • Herbaceous
      • Woody
      • Spicy
      • Floral
      • Citrus
      • Earthy
      • Camphoraceous
      • Others
    • Blends
  • Carrier Oils
• Equipment
  • Ultrasonic
  • Nebulizing
  • Evaporative
  • Heat

Aromatherapy Mode of Delivery Outlook (Revenue, USD Million, 2017 - 2028)

• Topical Application
• Aerial Diffusion
• Direct Inhalation

Aromatherapy Application Outlook (Revenue, USD Million, 2017 - 2028)

• Relaxation
• Skin & Hair Care
• Pain Management
• Cold & Cough
• Insomnia
• Scar Management
• Others

Aromatherapy Distribution Channel Outlook (Revenue, USD Million, 2017 - 2028)

• DTC
  • Retail
  • E-commerce
• B2B

Aromatherapy End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Home Use
• Spa & Wellness Centers
• Hospitals & Clinics
• Yoga & Meditation Centers

Aromatherapy Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Argentina
  • Mexico
  • Brazil
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Aromatherapy Market

• dōTERRA
• Young Living Essential Oils
• Edens Garden
• Mountain Rose Herbs
• Plant Therapy Essential Oils
• Rocky Mountain Oils, LLC
• FLORIHANA
• Falcon
• Biolandes
• Stadler Form Aktiengesellschaft
• Hubmar International
• SpaRoom

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Therapy Market Growth in the Coming Years

 Cell Therapy Market Growth & Trends

The global cell therapy market size is expected to reach USD 23.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.5% from 2021 to 2028. The emergence of new technologies to support the development of advanced cellular therapies has aided in market growth. Companies are leveraging new technologies not only for the expansion of their product portfolio but also for establishing out-licensing or co-development agreements with other entities to support their product development programs.

Cell-based therapies hold great potential for replacing, repairing, restoring, or regenerating damaged tissues, and organs. Researchers are making huge investments in the development of such effective and safe treatments as an alternative to conventional treatment strategies which can be further attributed to the market growth. Out of all therapeutic areas, oncology has the highest number of ongoing clinical trials. T cells, CD34+ and/or CD133+ stem cells, mesenchymal stem/stromal cells are predominantly employed for clinical investigation.

The majority of biopharmaceutical entities have been affected by the COVID-19 pandemic, while several cellular therapy development companies have witnessed a strongly negative impact, which can be attributed to complications in logistics as well as the manufacturing models employed in this industry. In addition, substantial and stable funding is imperative to ensure successful commercial translation of cell-based therapeutics, a factor that was negatively affected in 2020, further affecting the market growth.

A survey conducted recently among executives of more than 15 European and U.S. cellular therapy companies indicated that disruption caused by the pandemic was significant, which demanded market entities to create strategies to sustain themselves and plan the next wave of innovative therapies.

Key issues faced by companies operating in the market include on-time delivery of therapies to patients at required clinical sites. In addition, the administration of these therapeutics poses several post-pandemic challenges. Hospitals are hesitant in offering services, owing to concerns over transmission of SARS-CoV-2, particularly to vulnerable individuals. Moreover, patients have not been able to visit cellular therapy centers either, owing to the lockdowns and travel bans.

Request a free sample copy or view report summary: Cell Therapy Market Report

Cell Therapy Market Report Highlights

• The research-use segment dominated the market and accounted for the highest revenue share in 2020 attributed to extensive research activities for developing effective cell and gene therapies
• Several cells such as neural, epithelial, bone marrow mononuclear, fibroblasts, corneal, antigen-presenting, and chondrocytes, are being explored for the development of novel therapies
• The clinical-use segment is expected to witness relatively slow growth through the forecast period owing to the limited number of FDA-approved cellular therapies
• Moreover, there is a withdrawal of several commercialized products and less number of approved products for clinical-use which further affects the growth of the clinical-use segment
• Based on the therapeutic area, the malignancies segment accounted for the largest revenue share in 2020 owing to the rising application of stem cells in treating various cancers such as acute myeloid leukemia, multiple myeloma, and non-Hodgkin lymphoma
• The autologous therapies segment accounted for the largest revenue share in 2020 and it continues the trend through the forecast period owing to the high survival rate associated with this transplant type and relatively high adoption rate
• The allogenic therapies segment is expected to witness gradual growth through the forecast period owing to the high risk of transplant rejection and high cost associated with allogenic transplants
• North America has emerged as the highest revenue-generating region in 2020 owing to extensive investments made by the federal bodies for expanding cellular therapy research in the region
• In Asia Pacific, the market is expected to witness a lucrative growth rate owing to relatively inexpensive manufacturing and operating units, the presence of a large regional population, and untapped potential

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cell-therapy-market

Cell Therapy Market Segmentation

Grand View Research has segmented the global cell therapy market on the basis of use-type, therapy type, and region:

Cell Therapy Use-type Outlook (Revenue, USD Million, 2017 - 2028)

• Clinical-use
  • By Therapeutic Area
    • Malignancies
    • Muscoskeletal disorders
    • Autoimmune disorders
    • Dermatology
    • Others
  • By Cell Type
    • Stem Cell Therapies
      • BM, Blood, & Umbilical cord-derived Stem Cells
      • Adipose-derived cells
      • Others
    • Non-stem Cell Therapies
  • Research-use

Cell Therapy Type Outlook (Revenue, USD Million, 2017 - 2028)

• Allogenic Therapies
• Autologous Therapies 

Cell Therapy Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of Cell Therapy Market

• Kolon TissueGene, Inc.
• Anterogen Co., Ltd.
• JCR Pharmaceuticals Co., Ltd.
• Castle Creek Biosciences, Inc.
• The Future of Biotechnology, MEDIPOST
• Osiris Therapeutics, Inc.
• PHARMICELL Co., Ltd
• Tameika Cell Technologies, Inc.
• Cells for Cells
• NuVasive, Inc.
• Vericel Corporation
• Celgene Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surgical Equipment Market With Strong Application and Scope By 2028

 Surgical Equipment Market Growth & Trends

The global surgical equipment market size is anticipated to reach USD 24.5 billion by 2028 registering a CAGR of 9.8%, according to a new report by Grand View Research, Inc. Developing surgical care infrastructure, the advent of minimally invasive surgical techniques, and increasing cases of cesarean deliveries are the factors contributing significantly to the growth of this market. An increasing number of hospital visits for surgeries, such as hip and knee replacement, hernia repair, gall bladder removal, and other urology ailments, is also anticipated to propel the market growth during the forecast period.

According to the National Joint Registry report published in 2018, the number of knee replacement procedures performed in the U.K. reached 102,177 in 2017 from 81,590 in 2014. Lump-sum payment pertaining to specialty surgical services paired with out-of-pocket-based healthcare in many middle-income countries is expected to restrain the market growth during the forecast period. According to the global surgery 2030 report, each year over 33 million individuals have to face catastrophic expenditure. In addition, due to the limitation of resources, such as personal protective equipment, surgical staff, OR rooms, inpatient beds, and blood products, the surgery appointment for many non-emergent patients was postponed during the pandemic.

This has negatively impacted the sales of surgical equipment in 2020. According to the Healthcare Financial Management Association report, in the U.S. the cancellation and rescheduling rate of elective surgeries in the period of April-July 2020 was approximately 50%. However, currently, with several countries lifting bans on elective surgeries and clinics resuming their surgical services, the demand for surgical equipment, especially single-use devices, is expected to rise driving the market growth.

Request a free sample copy or view report summary: Surgical Equipment Market Report

Surgical Equipment Market Report Highlights

• The surgical sutures & staplers product segment held the largest market share in 2020 and will expand further at a steady CAGR from 2021 to 2028
• This growth is attributed to technological advancements, such as drug-eluting sutures and absorbable staples
• The electrosurgical devices segment is anticipated to register the fastest CAGR of 11.2% during the forecast period
• The obstetrics & gynecology application segment accounted for the largest revenue share in 2020
• However, plastic & reconstructive is estimated to be the fastest-growing application segment at a CAGR of 11.0% over the forecast period
• North America was the leading regional market in 2020 as the U.S. is one of the major suppliers of surgical equipment globally
• The Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to high unmet surgical needs in emerging economies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-surgical-equipment-market

Surgical Equipment Market Segmentation

Grand View Research has segmented the global surgical equipment market on the basis of product, application, and region:

Surgical Equipment Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Surgical Sutures & Staplers
• Handheld Surgical Devices
  • Forceps & Spatulas
  • Retractors
  • Dilators
  • Graspers
  • Auxiliary Instruments
  • Cutter Instruments
  • Others
• Electrosurgical Devices

Surgical Equipment Application Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Neurosurgery
• Plastic & Reconstructive Surgery
• Wound Closure
• Obstetrics & Gynecology
• Cardiovascular
• Orthopedic
• Others

Surgical Equipment Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Surgical Equipment Market

• Smith & Nephew plc
• Zimmer Biomet Holdings, Inc.
• Braun Melsungen AG
• Medtronic PLC
• Stryker Corporation
• Ethicon, Inc.
• Aspen Surgical Products, Inc.
• Alcon Laboratories, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Smart Card In Healthcare Market is Anticipated to Upgrade USD 2.46 Billion Revenue By 2028: Grand View Research Inc.

 Smart Card In Healthcare Market Growth & Trends

The global smart card in healthcare market size is expected to reach USD 2.46 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 12.4% from 2021 to 2028. Growing initiatives by market players and governments of various countries for the implementation of smart cards in the healthcare system are fueling market growth. Furthermore, compliance with smart cards with HIPAA as well as ARRA is expected to boost the market growth.

Similar to other markets, the market for smart card in healthcare has also been significantly affected by COVID-19. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, and low demand. Companies such as Thales Group reported flat growth in their smart cards product segment. Therefore, the overall impact of COVID-19 on the market was neutral.

The flexibility provided by smart cards to securely add information to a patient healthcare card after its issuance is expected to boost the market growth. This factor delivers various benefits for healthcare applications. Patient prescriptions can be written to the card, providing up-to-date information when a patient is receiving medical care from multiple providers or in an emergency; patient record identification or multiple patient identification numbers can be saved to the smart card, enabling record exchange as well as helping with care coordination amongst multiple healthcare providers; and patient healthcare information can be saved to and updated on the card by certified healthcare providers, with updated information available for both the healthcare providers and patient to access.

The market is fairly competitive owing to the presence of the most notable participants, along with other manufacturers of smart cards for healthcare applications. These players are involved in new product launches, acquisitions, and partnerships to gain a competitive advantage over each other. For instance, in March 2020, CardLogix Corporation launched a new edition of BIOSID, a rugged biometric tablet solution. With this, it expanded its product portfolio.

Request a free sample copy or view report summary: Smart Card In Healthcare Market Report

Smart Card In Healthcare Market Report Highlights

• By product type, the contactless segment held the dominant share of over 28.0% in 2020 owing to its high demand globally
• Based on component, the microcontroller-based smart cards segment held the largest share of more than 55.0% in 2020 owing to the portability and large memory capabilities of these smart cards
• In 2020, Europe held the dominant share of over 30.0% owing to the presence of major market players in the region and government initiatives to implement smart cards in the healthcare system
• Asia Pacific held the second-largest revenue share in 2020 and is expected to witness the fastest growth over the forecast period. The growing digitalization of healthcare systems in countries, such as India, is fueling the market growth
• North America is expected to witness lucrative growth over the forecast period owing to the technologically advanced healthcare infrastructure, paired with favorable government initiatives

Access Press Release@ https://www.grandviewresearch.com/press-release/global-smart-card-healthcare-market

Smart Card In Healthcare Market Segmentation

Grand View Research has segmented the global smart card in healthcare market on the basis of product type, component, and region:

Smart Card In Healthcare Product Type Outlook (Revenue, USD Million, 2016 - 2028)

• Hybrid
• Contactless
• Contact-based
• Dual-interface

Smart Card In Healthcare Component Outlook (Revenue, USD Million, 2016 - 2028)

• Memory-card Based
• Microcontroller Based

Smart Card In Healthcare Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Smart Card In Healthcare Market

• Atos SE
• Giesecke+Devrient GmbH
• Infineon Technologies AB
• NXP Semiconductors
• Texas Instruments Incorporated
• Thales Group
• CardLogix Corporation
• IDenticard Systems

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cerebrospinal Fluid Drainage Catheter Market is Growing at Significant Rate, 2028: Grand View Research Inc.

 Cerebrospinal Fluid Drainage Catheter Market Growth & Trends

The global cerebrospinal fluid drainage catheter market size is expected to reach USD 361.75 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.5% from 2021 to 2028. Increasing incidences of neurological disorders, coupled with a subsequent rise in the number of surgical procedures to treat associated conditions, are expected to drive the market.

Increasing incidence of cranial and spinal injuries, trauma, and other inflammatory diseases of the cerebrospinal space is expected to promote market growth over the forecast period. For instance, as per the National Spinal Cord Injury Statistical Center estimates in 2020, approximately 294,000 Americans are currently living with SCI and 17,810 new cases of SCI are reported each year.

However, the COVID-19 emergency has negatively impacted the current market for Cerebrospinal Fluid (CSF) drainage catheters in various conducts, such as shortage of healthcare professionals and treatments for individuals suffering from neurological disorders or other medical illness during the COVID-19 pandemic. In addition, the supply chain, manufacturing activities, delivery schedules, and sales of neurological products have been disrupted owing to the restrictions at international borders, thereby affecting the market growth for the short term.

Moreover, the integration of modern technologies and the launch of innovative products by market players are likely to augment the market growth over the forecast period. For instance, in September 2017, Arkis BioSciences (Integra LifeSciences) secured FDA clearance for its new EVD catheter CerebroFlo, which is used for insertion into the ventricular cavity for CSF drainage. This catheter is currently available in the U.S. and indicated for temporary use in patients with intraventricular hemorrhage or raised intracranial pressure.

Request a free sample copy or view report summary: Cerebrospinal Fluid Drainage Catheter Market Report

Cerebrospinal Fluid Drainage Catheter Market Report Highlights

• Based on type, the ventricular drainage catheter segment dominated the market with a share of more than 70.0% in 2020 owing to the escalating cases of neurological disorders such as hemorrhagic and ischemic strokes, intracranial tumors, brain infection, and aneurysm
• On the basis of application, the traumatic brain injury (TBI) segment dominated the market with a share of over 40.0% in 2020 owing to the high prevalence of TBIs globally, which leads to the leakage of CSF in the brain
• North America dominated the market with a revenue share of over 35.0% in 2020 owing to the high prevalence rate of cerebrovascular disorders and TBIs. As per the CDC, each year, an estimated 1.5 million Americans sustain TBIs

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cerebrospinal-fluid-drainage-catheter-market

Cerebrospinal Fluid Drainage Catheter Market Segmentation

Grand View Research has segmented the global cerebrospinal fluid drainage catheter market on the basis of type, application, and region:

CSF Drainage Catheter Type Outlook (Revenue, USD Million, 2016 - 2028)

• Lumbar Drainage Catheter
• Ventricular Drainage Catheter

CSF Drainage Catheter Application Outlook (Revenue, USD Million, 2016 - 2028)

• Traumatic Brain Injury
• Traumatic Spinal Injury
• Subarachnoid hemorrhage
• Intracerebral hemorrhage
• Others

CSF Drainage Catheter Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Cerebrospinal Fluid (CSF) Drainage Catheter Market

• Natus Medical, Inc.
• Desu Medica
• Spiegelberg GmbH & Co. KG
• Integra LifeSciences Corporation
• Medtronic
• Moller Medical GmbH
• Sophysa SA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Caps And Closures Market Will See Strong Expansion Through 2030: Grand View Research Inc.

 Caps And Closures Market Growth & Trends

The global caps and closures market size is expected to surpass USD 143,699.6 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.0% over the forecast period. The market is projected to be driven by the growth in the food & beverage industry across the globe, contributing to an increased usage of packaging products.

Rising counterfeiting activities in the alcoholic beverages market are likely to boost demand for anti-tamper or tamper-evident closure. For instance, Everledger launched a new line of anti-tamper closures for wine and spirit bottles in April 2020, wherein the bottle cap is provided with Near Field Communication (NFC)-powered tamper detection label. The label, in turn, will allow the beverage manufacturer to track the bottle during shipping. This is anticipated to fuel the need for tamper-evident bottle closures of alcoholic beverages.

Peanut butter, jellies, ketchup, and other spreadable & condiments are widely used in households and foodservice restaurants in countries, such as the U.S and Canada. As per YouGov America’s survey result published in August 2019, about 66% of the surveyed individuals ‘really like’ or ‘somewhat like’ the peanut butter & jelly sandwich. This, in turn, is expected to boost demand for dispensing caps & screw closures used for sealing containers of various spreadable items.

Closures play an important part in protecting canned food from moisture and dust particles. As per data released by the U.S. Department of Agriculture, about 31.4 pounds of tomatoes were available per person for consumption, after adjusting for losses, in the U.S. in 2019, of which 60% were available in canned form. Consumer preference for canned foods due to their multiple benefits is anticipated to augment demand for can metal ends.

The screw closures segment accounted for the second-highest share of 29.1% in 2020. Screw caps are used for closing containers of liquid products, such as beverages, edible oils, syrups, and motor oil. As per the Department of Food and Public Distribution, Government of India, the net availability of edible oils from all domestic sources was 8,630 thousand tons in 2015-16, which increased to an estimated volume of 10,655 thousand tons in 2019-20 in India. Therefore, the increasing demand for liquid product packaging solutions is expected to drive the segment growth.

The cosmetics & toiletries application segment held a significant market share and is expected to register the fastest CAGR from 2021 to 2030. Cosmetic usage is increasing worldwide, which is expected to propel the demand for cosmetic packaging products. Players are focusing on developing new closures designs that are convenient to open and close as well as offer excellent seals. For instance, Berry Global Inc. introduced PalmSoft child-resistant closure for beauty and personal care products in 2018. This closure provides soft rubber feel at the top with an enhanced grip for patients with arthritis and other individuals facing difficulty in opening the bottle.

Players are focusing on making plastic closure sustainable by using recycled packaging materials. For instance, in September 2020, Coca-Cola North America introduced caps made from recycled High-Density Polyethylene (HDPE) plastic for DASANI bottles. Similarly, 20-oz., half-liter, and 1-liter PET bottles of Reyes Coca-Cola have re-sealable closures that are derived from 30% recycled content.

Request a free sample copy or view report summary: Caps And Closures Market Report

Caps And Closures Market Report Highlights

• The metal segment is projected to grow at a CAGR of 4.8% from 2021 to 2030 due to rising usage of metals on account of higher durability and sustainability than plastic
• As per CAN manufactures Institutes’ 2019-20 Annual Report, total metal cans shipped from the U.S. were 125,123 million in 2018 that increased to 127,042 million in 2019 that are used for various food and beverage products
• Furthermore, the COVID-19 pandemic is expected to increase the demand for energy-boosting drinks, protein shakes, and dietary supplements that promote health and improve the immune system
• This, in turn, is expected to fuel demand for food-grade packaging solutions including caps & closures in the near future
• Companies in the caps & closures industry are adopting various strategies, such as capacity expansion and strengthening market presence through mergers & acquisitions
• For instance, in June 2020, Silgan acquired Albéa Group's 10 manufacturing facilities under its dispensing operations. This acquisition is expected to aid Silgan to expand its closures franchise along with dispensing systems operations

Access Press Release@ https://www.grandviewresearch.com/press-release/global-caps-closures-market

Caps And Closures Market Segmentation

Grand View Research has segmented the global caps and closures market on the basis of material, product, application, and region:

Caps & Closures Material Outlook (Revenue, USD Million, 2017 - 2030)

• Plastic
• Metal
• Others

Caps & Closures Product Outlook (Revenue, USD Million, 2017 - 2030)

• Dispensing Caps
• Screw Closures
• Crown Closures
• Aerosol Closures
• Others

Caps & Closures Application Outlook (Revenue, USD Million, 2017 - 2030)

• Food
• Beverages
  • Functional Beverages
    • CBD Beverages
  • Healthcare
  • Cosmetics & Toiletries
  • Automotive
  • Pharmaceutical
    • Dietary Supplements
  • Others

Caps & Closures Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
• Central & South America (CSA)
  • Brazil
• Middle East & Africa (MEA)
  • Saudi Arabia

List of Key Players of Caps And Closures Market

• Crown
• Amcor plc
• Closure Systems International
• Ball Corp.
• Silgan Holding, Inc.
• Berry Global, Inc.
• AptarGroup, Inc.
• BERICAP
• Nippon Closures Co. Ltd.
• Sonoco Products Company

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Membrane Oxygenators Market Trends, Growth Prospects To 2028: Grand View Research Inc.

 Membrane Oxygenators Market Growth & Trends

The global membrane oxygenators market size is expected to reach USD 141.5 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 1.5% from 2021 to 2028. Key factors expected to boost the market include the growing prevalence of respiratory failures and cardiopulmonary diseases. Furthermore, there has been a rise in the number of patients suffering from COVID-19 and chronic obstructive pulmonary disease, which can require membrane oxygenators for treatment, enhancing their adoption. Technological advancements in medical devices are expected to further propel their demand in hospitals.

Leading market participants operating in this industry are focusing on developing technologically advanced membrane oxygenators. For instance, in January 2019, Terumo Medical Corporation launched the smallest, lowest prime volume, full-size adult oxygenator-Capiox NX19-with Ultraprime technology. Significant features of this device are it minimizes inflammatory response and provides higher efficiency microemboli removal. Portable adaptors and compact membrane oxygenators in ECMO circuits have also been developed, which help in the transportation of critically ill patients. The recent developments in medical devices are estimated to drive market growth.

Cardiovascular diseases are among the leading causes of death across the globe. As per the WHO, in 2016, around 17.9 million CVD-related deaths were reported globally. A membrane oxygenator is used to treat patients with cardiac and respiratory diseases. ECMO machine removes carbon dioxide and delivers oxygen in patients when the lungs and heart fail to carry out the process of blood oxygenation. Hence, the rising occurrence of cardiac and respiratory disorders is anticipated to create robust growth opportunities.

Request a free sample copy or view report summary: Membrane Oxygenators Market Report

Membrane Oxygenators Market Report Highlights

• North America accounted for the largest revenue share in 2020 owing to the growing innovation in healthcare technologies, reducing healthcare expenditure, and increasing demand for membrane oxygenator devices in hospitals
• By type, the hollow fiber membrane oxygenator segment accounted for the largest revenue share in 2020, as they offer support after cardiac shock as a fast response system
• By application, the cardiac segment is expected to grow at an exponential rate over the forecast period, due to the increasing incidence of cardiac conditions such as cardiac arrest and myocardial infarction
• The neonates segment held a significant market share in 2020, due to increasing incidence of acute respiratory distress syndrome, congenital diaphragmatic hernia, air leak syndrome, respiratory failure, persistent pulmonary hypertension, and pneumonia
• The key companies focus on new product launches, strategic acquisitions, and mergers to attain a larger market share

Access Press Release@ https://www.grandviewresearch.com/press-release/global-membrane-oxygenators-market

Membrane Oxygenators Market Segmentation

Grand View Research has segmented the global membrane oxygenators market based on type, application, age group, and region:

Membrane Oxygenator Type Outlook (Revenue, USD Million, 2016 - 2028)

• Hollow Fiber
• Flat Sheet

Membrane Oxygenator Application Outlook (Revenue, USD Million, 2016 - 2028)

• Respiratory
  • Respiratory failure
  • Pulmonary embolism
  • Acute respiratory distress syndrome
  • Pneumonia
  • COVID-19
• Cardiac
  • Acute myocardial infarction
  • Myocarditis
  • Post-transplant complications
  • Decompensated cardiomyopathy
  • Cardiogenic shock
• ECPR

Membrane Oxygenator Age Group Outlook (Revenue, USD Million, 2016 - 2028)

• Neonates
• Pediatrics
• Adults

Membrane Oxygenator Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Membrane Oxygenators Market

• Medtronic
• Fresenius SE & Co KGaA
• Getinge AB
• Terumo Medical Corporation
• MicroPort Scientific Corporation
• Nipro Medical Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Industrial Computed Tomography Market Major Key Players And Latest Trend Analysis Till 2028: Grand View Research Inc.

 Industrial Computed Tomography Market Growth & Trends

The global industrial computed tomography market size is expected to reach USD 765.8 million by 2028, registering a CAGR of 7.5% from 2021 to 2028, according to a new report by Grand View Research, Inc. The increasing use of CT scanners in industries, such as automotive, electronics, oil & gas, and aerospace among several others, is anticipated to boost the market growth over the forecast period. Moreover, a rise in the demand for advanced electronics is expected to support market growth.

Industrial computed tomography systems are increasingly being used for inspecting and testing the internal and external structure & design of various complex parts and components without destructing/disassembling the product. Additive manufacturing technology is increasingly being used for the production of multiple complex parts and structures. Therefore, to inspect the product’s conformity with the original CAD designs, industrial CT scanners are used to determine the structure, dimensions, design, and tolerance of these products without altering their structure/form.

The benefits offered by industrial CT scanners, including manufacturing cost reduction, improved product design, and performance, as well as reduced product failure instances, are also expected to boost their adoption amongst the manufacturers. Moreover, these scanners provide high-quality inspection images that ease the inspection process and provide detailed information about the product under examination. Furthermore, assembly analysis is increasingly being done using the industrial computed tomography systems in the automotive industry that does not require the assembled systems to be disassembled for inspection. These benefits are expected to drive market growth over the forecast period.

Request a free sample copy or view report summary: Industrial Computed Tomography Market Report

Industrial Computed Tomography Market Report Highlights

• The market is majorly driven by the growing need to improve the overall product quality and reduce product recall instances
• The service segment is anticipated to register the fastest CAGR from 2021 to 2028 due to the high cost of CT scanner equipment
• The flaw detection & inspection segment held the largest share in 2020 and is also anticipated to register the fastest CAGR from 2021 to 2028
• The electronics vertical segment is expected to record the fastest CAGR of over 8.5% during the forecast period
• This growth is credited to the growing demand for various electronic devices, such as smartphones, tablets, and laptops
• North America was the largest regional market in 2020 due to the high manufacturing activities in the region across various industries, such as automotive, electronics, and oil & gas

Access Press Release@ https://www.grandviewresearch.com/press-release/global-industrial-computed-tomography-market

Industrial Computed Tomography Market Segmentation

Grand View Research has segmented the global industrial computed tomography market on the basis of offering, application, vertical, and region:

Industrial CT Offering Outlook (Revenue, USD Million, 2017 - 2028)

• Equipment
  • Line Beam Scanners
  • Cone Beam Scanners
• Services

Industrial CT Application Outlook (Revenue, USD Million, 2017 - 2028)

• Flaw Detection & Inspection
• Failure Analysis
• Assembly Analysis
• Dimensioning & Tolerancing Analysis
• Others

Industrial CT Vertical Outlook (Revenue, USD Million, 2017 - 2028)

• Oil & Gas
• Aerospace and Defense
• Automotive
• Electronics
• Others

Industrial CT Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

List of Key Players of Industrial Computed Tomography Market

• Nikon Metrology NV
• OMRON Corp.
• Baker Hughes Company
• YXLON International
• ZEISS Group
• VJ Group
• Rigaku Corp.
• Shimadzu Corp.
• Werth, Inc.
• North Star Imaging, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

MiRNA Sequencing And Assay Market Is Projected To Reach Approximately USD 597.8 Million By 2028: Grand View Research Inc.

 miRNA Sequencing And Assay Market Growth & Trends 

The global miRNA sequencing and assay market size is expected to reach USD 597.8 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.0% from 2021 to 2028. Prominent players, such as Illumina, PerkinElmer, Qiagen, and others offer advanced miRNA sequencing products for multiple clinical applications. Moreover, these companies have collaborated with research institutes to expand the application of miRNA sequencing and assay in research studies.

The market holds a significant growth potential owing to the increasing application of miRNA sequencing and assay in the healthcare industry. For instance, several research studies demonstrate that miRNAs can be used as efficient biomarkers in the diagnosis and prognosis of cancer (breast, ovarian, cervical, and others), cardiovascular diseases, sepsis, and nervous system disorders. Therefore, miRNA sequence analysis is increasingly employed to analyze gene regulation in clinical disorders.

As plasma from COVID-19 recovered patients is rich in antiviral miRNAs and antibodies, it has been employed to treat SARS-CoV-2 infected patients. This has led to an increase in research studies that focus on the sequence analysis of miRNAs (microRNA) from the patient as well as the virus.

Request a free sample copy or view report summary: miRNA Sequencing And Assay Market Report

miRNA Sequencing And Assay Market Report Highlights

• The product segment dominated the market and accounted for the largest revenue share in 2020. The commercial presence of multiple players that offer extensive kits, consumables, and instruments for specialized applications contribute to segment growth
• Small and mid-sized research entities face financial limitations to install sequencing equipment owing to their high cost. Therefore, these organizations approach service providers. This is expected to drive the services segment with the fastest CAGR over the forecast period
• Sequencing by synthesis holds a major share of the technology segment owing to its high sensitivity, fast turnaround time, and high throughput
• Additionally, this technology is playing important role in the detection of mutations in tumor tissue which helps to develop targeted and personalized therapies
• The sequencing workflow segment held the largest revenue share in 2020 and is expected to witness the fastest CAGR during the forecast period as it is the most important and crucial step of the workflow
• The cancer application segment generated the largest revenue share in 2020 owing to ongoing extensive research in cancer using miRNA as a biomarker to study diagnosis and prognosis of cancer and to develop novel therapies
• Furthermore, an increase in the number of cancer patients globally drives segment growth
• Research and academic institutions are one of the major revenue generators of the market as miRNA sequencing and assay techniques and associated products are being widely used in various research studies conducted by research and academic institutes
• In Asia Pacific, the market is anticipated to register a lucrative growth rate throughout the forecast owing to the presence of a huge target population, growing establishment of healthcare, and high unmet clinical needs

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mirna-sequencing-assay-market

miRNA Sequencing And Assay Market Segmentation

Grand View Research has segmented the global miRNA sequencing and assay market on the basis of product & service, technology, workflow, application, end-use, and region:

miRNA Sequencing And Assay Product & Service Outlook (Revenue, USD Million, 2017 - 2028)

• Products
  • Library Preparation Kits
  • Sequencing Consumables
  • Instruments
• Services

miRNA Sequencing And Assay Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Sequencing (Seq.) By Synthesis
• By Oligonucleotide Ligation and Detection (SOLiD)
• Nanopore Seq.
• Sanger Seq.
• Single Molecule Real-time (SMRT) Seq.

miRNA Sequencing And Assay Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Library Preparation
• Sequencing
• Data Analysis & Storage

miRNA Sequencing And Assay Application Outlook (Revenue, USD Million, 2017 - 2028)

• Cancer
• Polyglutamine Diseases
• Autoimmune Disease
• Schizophrenia
• Others

miRNA Sequencing And Assay End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Pharmaceutical & Biotechnology Industry
• Research and Academic Institutes
• Contract Research Organizations

miRNA Sequencing And Assay Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Market Players of miRNA Sequencing And Assay Market

• Thermo Fisher Scientific, Inc
• Illumina, Inc.
• QIAGEN
• PerkinElmer, Inc.
• Abcam plc
• New England Biolabs
• Takara Bio Inc.
• Lexogen GmbH
• Norgen Biotek Corp
• Maravai LifeSciences
• HTG Molecular Diagnostics, Inc.
• Meridian Bioscience, Inc.
• System Biosciences, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Cancer Biopsy Market Predicted to Witness Steady Growth During the Forecast Period

 U.S. Cancer Biopsy Market Growth & Trends

The U.S. cancer biopsy market size is expected to reach USD 15.98 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.0% from 2021 to 2028. The increasing usage of technologically advanced devices for the early detection of diseases is one of the key factors driving the market.

A significant transaction from tumor to liquid biopsy is anticipated to increase the adoption of this technique in the market. Acknowledging this trend, several operating entities have undertaken various initiatives to expand their biopsy kits portfolio. For instance, in June 2021, Biocept, Inc. and Quest Diagnostics collaborated to offer NGS-based liquid biopsy testing for lung cancer diagnosis.

Furthermore, supportive regulatory and reimbursement scenarios in the country have supplemented the market growth. The U.S. FDA is actively engaged in supporting the commercialization of cancer biopsy products and increasing the use of these assays in clinics. For instance, in March 2021, the U.S. FDA granted a breakthrough device designation to RaDaR-a liquid biopsy assay to detect minimal residual disease in early-stage cancer.

Request a free sample copy or view report summary: U.S. Cancer Biopsy Market Report

U.S. Cancer Biopsy Market Report Highlights

• The fine-needle aspiration type segment accounted for the largest revenue share in 2020 owing to it being a well-established approach for the initial diagnosis of most of the body lesions. Among various biopsy techniques, fine-needle aspiration has witnessed significant popularity in diagnostics
• By type, the others segment is expected to expand at the fastest CAGR of 15.2% from 2021 to 2028. Liquid biopsies are anticipated to witness considerable growth over the forecast period due to the advancements and increasing regulatory approvals in the U.S.
• Screening and monitoring emerged as a dominant application segment in 2020. Follow-up or repeat biopsy procedures are fueling the growth of this segment
• Key players are collaborating with biopharma developers to support their product development process

Access Press Release@ https://www.grandviewresearch.com/press-release/us-cancer-biopsy-market-analysis

U.S. Cancer Biopsy Market Segmentation

Grand View Research has segmented the U.S. cancer biopsy market on the basis of type, application, and site (organ):

U.S. Cancer Biopsy Type Outlook (Revenue, USD Million, 2017 - 2028)

• Fine-needle Aspiration
  • Pharma-use
  • Clinical-use
• Core Biopsy
  • Pharma-use
  • Clinical-use
• Surgical Biopsy
  • Pharma-use
  • Clinical-use
• Skin Biopsy /Punch Biopsy
  • Pharma-use
  • Clinical-use
• Others
  • Pharma-use
  • Clinical-use

U.S. Cancer Biopsy Application Outlook (Revenue, USD Million, 2017 - 2028)

• Screening & Monitoring
• Diagnostics
• Investigational & Translational Research
• Pharma & Biopharma Discovery & Development

U.S. Cancer Biopsy Site (Organ) Outlook (Revenue, USD Million, 2017 - 2028)

• Liver
• Breast
• Thyroid
• Prostate Gland
• Uterus & Cervix
• Kidney
• Bladder
• Lungs
• Pancreas
• Others

List of Key Players of U.S. Cancer Biopsy Market

• Becton, Dickinson and Company
• IZI Medical Products
• Johnson & Johnson
• Argon Medical
• Cook Medical
• Spectra Medical Devices, Inc.
• Medtronic plc.
• Boston Scientific Corporation
• Conmed Corporation
• INRAD, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.